Fabtech Technologies Limited (FABTECH)

Loading page…

Fabtech Technologies Limited (FABTECH) · mywealthgrid

About

Fabtech Technologies Limited operates in medical equipment and supplies within the healthcare sector, with a market capitalization of ₹657.58 Cr. Consolidated revenues reached ₹158.52 Cr in Mar 2026, positioning the company as a mid-cap healthcare equipment player. Current metrics (PE 13.5, ROE 12.94%) reflect modest profitability amid significant quarterly volatility.

Face value: ₹10

Market cap

₹632 Cr

P/E

13.0×

P/B

1.5×

Dividend yield

0.4%

ROE

12.9%

ROCE

15.5%

Debt / equity

0.1

OPM

8.5%

EPS (TTM)

₹11.0

Book value

₹94.4

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Operating margins swung from 28.36% (Sep 2025) to -18.26% (Dec 2025), currently at 8.52%, indicating demand cyclicality or operational distress
Net loss of ₹5.68 Cr (Dec 2025) and EPS volatility ranging from ₹8.68 to -₹1.56 across quarters raise earnings sustainability and working capital management concerns
Minimal institutional ownership (FII 0.02%, DII 2.45%) suggests limited analyst coverage; verify customer concentration and competitive positioning
Verify exposure to government procurement cycles versus private hospitals and order visibility to assess demand trajectory

Generated analysis · source review pending

Growth drivers

Consolidated revenue of ₹158.52 Cr (Mar 2026) represents scale achieved with potential earnings recovery if Jun 2026 compression to ₹74.98 Cr reflects seasonal pattern
Historical operating margins of 28.36% (Sep 2025) versus current 8.52% indicate significant profit expansion upside if normalized
Low D/E ratio of 0.1 provides financial capacity for debt-funded investment in capex or working capital to support growth
Verify whether recent margin compression reflects price pressure, volume loss, demand cyclicality, or temporary operational disruption

Generated analysis · source review pending

241 historical price candles were omitted because the exchange source has not been verified.

₹142.0-3.7%1Y

Quick read

rule-based

Pros

+Strong return on equity of 22.7% (3-yr avg)
+High return on capital employed of 24.7%
+Profit CAGR of 20.9% over the last 3 years
+Revenue CAGR of 28.5% over the last 3 years
+Comfortable interest coverage of 12.1×
+High promoter holding of 68.9% with no pledge

Cons

−Low dividend payout of 5.5% of profit

Research score

Structured signal from quality, growth, valuation and momentum.

69/100

Business quality: 51
Growth: 73

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Molbio Diagnostics LimitedMOLBIOMOLBIO	₹17,431 Cr	₹17,844 Cr	₹1,020 Cr	₹262 Cr	25.7%	₹145 Cr	13.6%	23.7%	16.2%	—
Poly Medicure LimitedPOLYMEDPOLYMED	₹16,610 Cr	₹16,952 Cr	₹1,997 Cr	₹461 Cr	23.6%	₹315 Cr	17.1%	14.5%	11%	294
Fischer Medical Ventures LimitedFISCHERFISCHER	₹2,190 Cr	₹2,262 Cr	₹367 Cr	₹50 Cr	14%	₹30 Cr	10.1%	13.6%	8.6%	111
Tarsons Products LimitedTARSONSTARSONS	₹1,752 Cr	₹2,135 Cr	₹441 Cr	₹119 Cr	27.9%	₹11 Cr	3.4%	5%	2.3%	361
Laxmi Dental LimitedLAXMIDENTLLAXMIDENTL	₹1,066 Cr	₹1,066 Cr	₹287 Cr	₹46 Cr	15.6%	₹31 Cr	10.4%	14.7%	12.8%	109
Hemant Surgical Industries LtdHSILHSIL	₹885 Cr	—	₹232 Cr	₹23 Cr	10%	₹18 Cr	7.9%	—	—	—
Fabtech Technologies LimitedFABTECHFABTECH	₹632 Cr	₹675 Cr	₹418 Cr	₹45 Cr	8.5%	₹49 Cr	9.3%	15.5%	12.9%	55
Prevest Denpro LtdPREVESTPREVEST	₹452 Cr	—	₹72 Cr	₹25 Cr	34.4%	₹20 Cr	28.5%	—	—	—
Nureca LimitedNURECANURECA	₹332 Cr	₹333 Cr	₹153 Cr	₹4 Cr	0.1%	₹4 Cr	1.4%	3.3%	1.1%	186
Earkart LtdEARKARTEARKART	₹179 Cr	₹179 Cr	₹54 Cr	₹8 Cr	15.5%	₹5 Cr	9.1%	12.1%	7.7%	243
Choksi Asia LtdCHOKSICHOKSI	₹117 Cr	₹119 Cr	₹11 Cr	₹-2 Cr	13.8%	₹2 Cr	10.8%	18.9%	13.5%	142
Shree Pacetronix LtdSHREEPACSHREEPAC	₹68 Cr	₹71 Cr	₹8 Cr	₹1 Cr	23.5%	₹0 Cr	14%	27.4%	18.9%	385

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	257	194	226	327	411
COGS	136	92	121	182	243
Gross profit	121	102	105	145	168
	89	80	71	107	133
	32	23	34	38	35
OPM %	12.5%	11.7%	15%	11.5%	8.6%
Depreciation	2	2	2	3	5
Interest	3	3	2	2	4
	3	6	4	27	22
Profit before tax	31	28	36	60	48
Tax	8	6	9	14	10
Tax %	25.2%	22.1%	23.9%	23.2%	20.6%
	23	22	27	46	38
PAT margin %	9.1%	11.2%	12%	14.2%	9.3%
EPS (₹)	—	—	—	—	10
EPS adjusted (₹)	—	—	—	—	8.6
	—	—	—	—	6%
Annual report	—	—	—	—	Annual report for Mar 2026

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	3	3	3	32	44
Reserves	65	86	129	141	375
	19	34	10	55	43
	86	91	127	199	191
Total equity & liabilities	172	214	269	427	654
	5	4	22	94	78
CWIP	—	—	—	—	—
Investments	17	20	21	15	26
	150	190	226	318	550
Total assets	172	214	269	427	654

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-3	-14	60	-36	0
	-9	2	-30	-20	-112
	8	12	-12	36	190
Net cash flow	-4	-0	18	-20	78
Free cash flow	—	—	—	—	-4
CFO / Operating profit %	-8.3%	-61.4%	178.3%	-95.9%	1.4%

Compounded sales growth

7 years: —
5 years: —
3 years: 29%
1 year: 26%

Compounded profit growth

7 years: —
5 years: —
3 years: 21%
1 year: -17%

Return on equity

7 years: —
5 years: 23%
3 years: 19%
Last year: 9%

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Rest of the world	143.66	0	70.36	0	70.36	0
UAE	126.66	0	37.1

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	47%	52.7%	46.4%	44.4%	40.9%
EBITDA margin %	12.5%	11.7%	15%	11.5%	8.5%
EBIT margin %	11.9%	10.7%	14.1%	10.7%	7.2%
PAT margin %	9.1%	11.2%	12%	14.2%	9.3%
Working capital
Receivable days	120	187	156	168	182
Inventory days	17	69	88	119	32
Payable days	—	—	—	—	159
NWC days	—	—	—	—	55
Leverage
Current ratio	1.46	1.48	1.7	1.37	2.5
Debt to EBITDA	0.58	1.51	0.29	1.45	1.22
Debt to equity	0.28	0.39	0.07	0.32	0.1
Interest coverage	10.7	10.4	19.1	21.2	12.1
Asset turnover	1.5	0.91	0.84	0.77	0.63
Return ratios
Return on assets %	13.7%	10.2%	10.1%	10.9%	5.9%
Return on capital employed %	46.8%	33%	32.1%	26.4%	15.5%
Return on equity %	34.8%	24.4%	20.6%	26.8%	9.1%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	68.94%	68.94%	68.94%	68.94%
	1.91%	0.03%	0.08%	0.02%
	11.63%	1.99%	2.15%	2.45%
Government	0%	0%	0%	0%
	17.52%	29.04%	28.83%	28.59%
No. of shareholders	57,162	31,755	28,620	29,408

Promoter holding up 0 percentage points since Sep 2025.

95 deals · 7 Oct 2025 – 16 Jun 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
16 Jun 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	3,21,928	₹161.79	₹5.21 Cr
16 Jun 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	3,21,928	₹161.65	₹5.20 Cr
28 Apr 2026	ARIHANT CAPITAL MARKETS LIMITED	Bulk	NSE	Sell	3,97,832	₹178.35	₹7.10 Cr
28 Apr 2026	ARIHANT CAPITAL MARKETS LIMITED	Bulk	NSE	Buy	3,97,832	₹177.93	₹7.08 Cr
28 Apr 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	2,98,091	₹176.74	₹5.27 Cr
28 Apr 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	2,98,091	₹176.64	₹5.27 Cr
27 Mar 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	5,92,541	₹158.86	₹9.41 Cr
27 Mar 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	5,92,541	₹158.97	₹9.42 Cr
27 Mar 2026	DHARMIK VITHTHALBHAI KAPURIYA	Bulk	NSE	Buy	2,68,554	₹158.75	₹4.26 Cr
27 Mar 2026	DHARMIK VITHTHALBHAI KAPURIYA	Bulk	NSE	Sell	2,68,554	₹158.87	₹4.27 Cr

1–10 of 95

1 / 10

Mr. Naushad Alimohmed PanjwaniNon-Executive - Independent Director-Chairperson
Mr. Chirag Himatlal DoshiNon-Executive - Non Independent Director
Mr. Amjad Adam ArbaniNon-Executive - Non Independent Director
Mr. Hemant Mohan AnavkarExecutive Director
Ms. Rupal Dhiren HariaNon-Executive - Independent Director
Ms. Bharti KhannaNon-Executive - Independent Director
Neetu Aditya TibrewalCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 1 fund houses

Held by these funds

of the company's equity

All mutual funds

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

1 schemes

		Shares
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	329	0	0.01%	0.001%	-0

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Annual Report FY2026from bse Summary

Offer and rights documents

Fabtech Technologies Limited — PROSPECTUSListing · 3 Oct 2025

Investor Presentation and earnings call

Jul 2026Transcript AI Summary PPT REC
Apr 2026Transcript AI Summary PPT

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Final dividend17 Aug 2026 · ex-date₹0.6

1

Board meeting to consider results24 Jul 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

28 announcementsExport CSV

30 Sept 2026, 7:29 pmCompany Update

Announcement under Regulation 30 (LODR)-Restructuring

Restructuring PDF

Loading announcements…

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	47%	52.7%	46.4%	44.4%	40.9%
EBITDA margin %	12.5%	11.7%	15%	11.5%	8.5%
EBIT margin %	11.9%	10.7%	14.1%	10.7%	7.2%
PAT margin %	9.1%	11.2%	12%	14.2%	9.3%
Working capital
Receivable days	120	187	156	168	182
Inventory days	17	69	88	119	32
Payable days	—	—	—	—	159
NWC days	—	—	—	—	55
Leverage
Current ratio	1.46	1.48	1.7	1.37	2.5
Debt to EBITDA	0.58	1.51	0.29	1.45	1.22
Debt to equity	0.28	0.39	0.07	0.32	0.1
Interest coverage	10.7	10.4	19.1	21.2	12.1
Asset turnover	1.5	0.91	0.84	0.77	0.63
Return ratios
Return on assets %	13.7%	10.2%	10.1%	10.9%	5.9%
Return on capital employed %	46.8%	33%	32.1%	26.4%	15.5%
Return on equity %	34.8%	24.4%	20.6%	26.8%	9.1%

Date	Category	Subject	Filing
30 Sept 2026, 7:29 pm	Company Update Restructuring	Announcement under Regulation 30 (LODR)-Restructuring	PDF
17 Sept 2026, 1:18 pm	Company Update Press Release / Media Release	Announcement under Regulation 30 (LODR)-Press Release / Media Release	PDF
11 Sept 2026, 10:26 am	Company Update Press Release / Media Release	Announcement under Regulation 30 (LODR)-Press Release / Media Release	PDF
26 Aug 2026, 1:12 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
24 Aug 2026, 6:06 pm	Company Update Change in Directorate	Announcement under Regulation 30 (LODR)-Change in Directorate	PDF
24 Aug 2026, 4:58 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Outcome of AGM	PDF
19 Aug 2026, 3:33 pm	Company Update Press Release / Media Release	Announcement under Regulation 30 (LODR)-Press Release / Media Release	PDF
3 Aug 2026, 5:25 pm	Company Update Earnings Call Transcript	Announcement under Regulation 30 (LODR)-Earnings Call Transcript	PDF

Fabtech Technologies Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Offer and rights documents

Investor Presentation and earnings call

Events

Dividends1

Board meetings1

Announcements

Ratio timeline

Not in the F&O segment

Dividends1

Board meetings1

Announcements

Annual reports

Offer and rights documents

Investor Presentation and earnings call

Quarterly record

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Segment results

Algeria · revenue

1

1

1

1